In pancreatic cancer, a molecular subtyping system with prognostic value was constructed by integrating NAT10-regulated gene expression profiles through bioinformatics analysis of TCGA pancreatic cancer cohorts. The gene discussed is NAT10; the disease is pancreatic neoplasm.